Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder, affecting 1 in 500 individuals globally. HCM varies from asymptomatic disease to a highly symptomatic obstructive HCM (oHCM).
This study characterized the Swedish HCM population and assessed healthcare utilization with...
O. Braun, A. Damlin, C. Christersson et al.· European Heart Journal· 0 citations
Type 2 diabetes (T2D) is associated with a substantially increased risk of heart failure, partly mediated by myocardial stress and neurohormonal activation. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) both improve cardiovascular outcomes in T2D, bu...
C. Lejonberg, A. Rosengren, T. Czuba et al.· European Heart Journal· 0 citations
Heart failure (HF) remains associated with high mortality despite therapeutic advances. In elderly patients, the cause, mode and location of death may be as clinically relevant as survival itself. However, contemporary population-level data across ejection fraction (EF) and etiological subtypes are limited....
A. Lyon, M. Lindgren, K. Konstantinou et al.· European Heart Journal· 0 citations
The HF incidence was high, with approximately 1 in 20 individuals developing HF within 5 years after diagnosis of diabetes other than type 1, highlighting a notably high risk of developing HF soon after diabetes diagnosis.
Carl Lejonberg, T. Czuba, Louise Bennet et al.· Diabetologia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.